Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 4, 2022
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
[ Fri, Nov 04th 2022
] - WOPRAI
Justin Kim Downgraded (AUPH) to Hold on, Nov 4th, 2022
Justin Kim of Oppenheimer, Downgraded "Aurinia Pharmaceuticals Inc." (AUPH) to Hold on, Nov 4th, 2022.
Justin has made no other calls on AUPH in the last 4 months.
There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Justin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Justin
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $26 on, Tuesday, August 9th, 2022
